Biotechnology

Tetra Bio-Pharma Hits Another Milestone Before Year End

December 16, 2020 6:30 AM

Tetra will accelerate its Inhaled synthetic THC drug approvals under a 505(b)(2) marketing application pathway FDA confirms clinical development program to support marketing application of Tetra's inhaled innovative THC drug OTTAWA, ON / ACCESSWIRE / December 16, 2020 / Tetra Bio-Pharma Inc. ("Tetra" or the "Company") (TSX:TBP)(OTCQB:TBPMF), a leader in cannabinoid-derived drug discovery and development, today announced it conducted a...

Read more

Helix Biopharma Corp. Announces Fiscal 2021 First Quarter Results

December 15, 2020 11:50 PM

RICHMOND HILL, ON / ACCESSWIRE / December 15, 2020 / Helix BioPharma Corp. (TSX:HBP), ("Helix" or the "Company"), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based on its proprietary technological platform DOS47, today announced its fiscal 2021 first quarter results for the period ending October 31, 2020. OVERVIEW The Company reported a net loss and total comprehensive loss of...

Read more

Ron Kilgarlin on How American Screening LLC Facilitates Efficient Decision-Making with Vast Selection of Rapid Drug Tests

December 15, 2020 5:40 PM

SHREVEPORT, LA / ACCESSWIRE / December 15, 2020 / Certain issues remain a common worldwide challenge despite the social progress and economic prosperity achieved in the past few decades. One of them is illicit drug use, which has been straining healthcare budgets, affecting workplace productivity, and endangering public safety. However, medical and technological advances have enabled government agencies, healthcare professionals, employers, and...

Read more

Hancock Jaffe Announces Significant Improvements in all Study Endpoints For Final VenoValve First-in-Human Data

December 15, 2020 4:15 PM

Patients Show Significant Improvements in Reflux, VCSS, and VAS Scores IRVINE, CA / ACCESSWIRE / December 15, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the final aggregated data for the VenoValve first-in-human trial shows significant improvements in all study endpoints. For the eleven patients in the first-in-human study,...

Read more

Apollo Endosurgery Receives FDA Clearance for the X-Tack(TM) Endoscopic HeliX Tacking System

December 15, 2020 4:00 PM

AUSTIN, TX / ACCESSWIRE / December 15, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures, announced today U.S. Food and Drug Administration 510k clearance of the X-Tack™ Endoscopic HeliX Tacking System. X-Tack is a new, through-the-scope, suture-based device designed specifically for closing and healing defects in the lower gastrointestinal...

Read more

Viewpoint Molecular Targeting(TM) Closes $8 Million in First Tranche of Series A Financing

December 15, 2020 11:00 AM

Company focused on developing precision α-particle radiopharmaceutical oncology drugs and complementary diagnostic imaging agents that have the potential to optimize patient care Funds from Series A expected to propel two lead radiopharmaceutical programs, VMT01 and VMT-𝛼-NET into Phase 1 imaging studies beginning before year-end 2020 and accelerate development of radioisotope production technologies CORALVILLE, IA / ACCESSWIRE /...

Read more

DPS and TRIA Complete First Phase for Arranta Bio's Manufacturing Facility

December 15, 2020 9:10 AM

BOSTON, MA / ACCESSWIRE / December 15, 2020 / DPS Group, a privately-owned, global engineering, procurement, construction management, and validation (EPCMV) firm serving high-tech process industries, and TRIA, a principal-led architecture firm with a focus on designing unique spaces for science, technology, and corporate clients, are pleased to announce the completion of the first phase of the 80,000 SF Arranta Bio Manufacturing Facility....

Read more

Nascent Biotech Receives Full IND Clearance to Begin Phase I Human Trials for Brain Cancer

December 15, 2020 8:00 AM

SAN DIEGO, CA / ACCESSWIRE / December 15, 2020 / Nascent Biotech, Inc. (OTCQB:NBIO) On December 7, the Company received a letter from the US Food and Drug Administration (FDA) removing a partial clinical hold on Nascent's proprietary monoclonal antibody Pritumumab. This allows Nascent to commence Phase I Human Clinical Trials, effective immediately. Nascent CEO Sean Carrick stated, "The approval by the FDA is a major milestone in Nascent's...

Read more

ThinkGenetic Announces Integration of Innovative Diagnostic Aid in Takeda Pilot Awareness Initiative

December 15, 2020 6:00 AM

BOSTON, MA / ACCESSWIRE / December 15, 2020 / ​ThinkGenetic, Inc. is set to launch three disease-specific versions of the diagnostic aid, SymptomMatcher™ for upcoming pilot awareness initiatives by global biopharmaceutical leader, Takeda Pharmaceutical Company Limited. Six pilots, which will be released publicly in 2021, create a tailored online interactive experience to help individuals determine if their health signs and symptoms could be...

Read more

Xenetic Biosciences, Inc. Announces Closing of $6.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

December 14, 2020 11:15 AM

FRAMINGHAM, MA / ACCESSWIRE / December 14, 2020 / Xenetic Biosciences, Inc. (NASDAQ:XBIO) ("Xenetic" or the "Company"), a biopharmaceutical company focused on advancing XCART™, a personalized CAR T platform technology engineered to target patient- and tumor-specific neoantigens, announced today the closing of its previously announced registered direct offering with several institutional and accredited investors for 2,448,980 shares of the...

Read more

Hancock Jaffe Announces One Year Follow-up Data on Eleventh VenoValve Patient

December 14, 2020 8:30 AM

Final Patient in First-in-Human Study Shows Significant Improvement at One Year IRVINE, CA / ACCESSWIRE / December 14, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)(NASDAQ:HJLIW), a developer of medical devices that restore cardiac and vascular health, announced today that the eleventh and final VenoValve patient in HJLI's first-in-human, clinical study has successfully reached the one-year milestone. Patient 11's chronic venous...

Read more

Applied UV Expands Executive Leadership Team with Appointment of Rhonda Wallen as Vice President of Product Marketing and Corporate Development

December 14, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / December 14, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultraviolet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced that Rhonda A. Wallen has joined the Company as Vice President of Product Marketing & Corporate Development. As part of the executive leadership and...

Read more

Mosaic ImmunoEngineering Inc. Provides an Overview of Development Plans for Advancing Its Lead Immuno-Oncology Product Candidate MI-O-101

December 14, 2020 8:00 AM

-Preclinical Data Published in Peer Reviewed Journals Support Advancing the Program into Human Clinical Trials- -Company Plans to Initiate Discussions with Regulatory Agencies in Early 2021 to Review Its Strategy for IND or Equivalent Filing- -Data Generated in Companion Animals with Naturally Occurring Tumors Support Potential Veterinary Applications- NOVATO, CA / ACCESSWIRE / December 14, 2020 / Mosaic ImmunoEngineering Inc., (the...

Read more

IN STOCK: COVID-19 Coronavirus 'Rapid Test Kits' For Immediate Delivery

December 11, 2020 8:10 AM

CHEYENNE, WY / ACCESSWIRE / December 11, 2020 / MJ Biotech, Inc. (OTCQB:MJTV), is pleased to announce that given the global COVID-19 (coronavirus) healthcare crisis and the nationwide acute shortage of testing supplies, MJ BIOTECH INC. has entered the Professional medical testing sector and has IN STOCK FOR IMMEDIATE DELIVERY Emergency Use Authorized COVID-19 "Coronavirus" IgG/IgM Rapid Test Kits. These Kits are very much in demand at...

Read more

Ron Kilgarlin of American Screening LLC - On Offering Comprehensive Choice of Urine and Saliva Drug Tests

December 10, 2020 6:15 PM

SHREVEPORT, LA / ACCESSWIRE / December 10, 2020 / American Screening LLC alongside its founder, Ron Kilgarlin, has been supporting efforts to combat substance abuse and addiction for nearly 17 years by providing a vast array of drug testing products and striving to offer the best possible prices without compromising on quality. This has helped the Shreveport, Louisiana-based company become an ISO13485 contract manufacturer and one of the leading...

Read more

DECN Secures Exclusive Distributor Agreement With a German Based Company for the Distribution of Genviro! Covid-19 :10 Saliva Testing Kits and Meters in 18 EU Countries, Norway and the UK

December 10, 2020 9:15 AM

WITH THIS DEAL THE TOTAL NUMBER OF COUNTRIES COVERED BY DECN INTERNATIONAL AGREEMENTS NOW APPROACHES 50 WITH MORE ANTICIPATED LOS ANGELES, CA / ACCESSWIRE / December 10, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) www.decisiondiagnostics.co, a leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters through its subsidiary Pharma Tech Solutions, Inc., today announced it has...

Read more

Applied UV Appoints Sales Veteran Robert Berger as Vice President of Global Sales

December 10, 2020 8:30 AM

MOUNT VERNON, NY / ACCESSWIRE / December 10, 2020 / Applied UV, Inc. (NASDAQ:AUVI) ("Applied UV" or the "Company"), an infection prevention technology company that applies the power of narrow-range ultraviolet light ("UVC") to destroy pathogens safely, thoroughly, and automatically, today announced that Robert Berger joined the Company as Vice-President Global Sales on December 7, 2020. As part of the executive leadership and reporting to the...

Read more

Hancock Jaffe to Provide VenoValve and CoreoGraft Updates at Ladenburg Thalmann R&D Showcase Webinar on December 16, 2020

December 10, 2020 8:30 AM

VenoValve and CoreoGraft Primary Investigators to Present at Webinar IRVINE, CA / ACCESSWIRE / December 10, 2020 / Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI), a developer of medical devices that restore cardiac and vascular health, today announced that on Wednesday, December 16, 2020, at 1:00 Eastern time, Ladenburg Thalmann will host an R&D Showcase Webinar for Hancock Jaffe at which HJLI will provide updates on the VenoValve and...

Read more

Heat Biologics Provides Business Update

December 10, 2020 8:00 AM

DURHAM, NC / ACCESSWIRE / December 10, 2020 / Heat Biologics, Inc. ("Heat") (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, including multiple oncology product candidates and a novel COVID-19 vaccine, today announced a planned reverse stock split of its shares of common stock at a ratio of 1-for-7. The reverse stock split will take effect as of 12:01 a.m. ET,...

Read more

Lexaria Closes Sale of Non-Pharmaceutical THC-Related Assets

December 10, 2020 6:50 AM

Asset Sale in Preparation for Potential US National Securities Exchange Listing KELOWNA, BC / ACCESSWIRE / December 10, 2020 / Lexaria Bioscience Corp. (OTCQX:LXRP)(CSE:LXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, announces that it has closed the sale of its non-pharmaceutical THC-related assets ("the Assets") held within Lexaria Canpharm ULC, a Lexaria wholly-owned subsidiary, to Hill Street Beverage...

Read more